Akebia Therapeutics, Inc.
$0.88
-0.06 (-6.51%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -34.9%
- 3 Months
- -13.9%
- YTD
- -45.4%
- 1 Year
- -70.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 77.3%
- Largest decline max drawdown, since Aug 2025
- -74.4%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.17
Own AKBA?
See how AKBA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.